Unapproved New Drugs/Misbranded
Similar Posts
BD Provides Update on Voluntary Recall of Certain BD Alaris™ Pump Infusion Sets
FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall initiated in the United States on July 8, 2025 and expanded on July 17, 2025 to inform customers of worst-case performancGreen Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products Following FDA Findings
Costa Mesa, California August 28, 2025 – Green Lumber Holding, LLC (“Green Lumber”) is alerting consumers that counterfeit products misrepresented as genuine Green Lumber have been identified and may pose health risks.Revance Therapeutics – 7/15/2022
Revance Therapeutics – 7/15/2022. Country: USA. Record Type: 483Albertsons Companies Stores in Arkansas, Louisiana, Oklahoma and Texas Voluntarily Expands Recall to Select Items Containing Tuna Salad from Reser’s Fine Foods Due to an Ingredient Recall Linked to Possible Listeria monocytogenes Contamination
Albertsons, Randalls and Tom Thumb stores in Arkansas, Louisiana, Oklahoma and Texas are voluntarily recalling select items containing tuna salad supplied by Reser’s Fine Foods. This action follows a recall initiated by Reser’s Fine Food due to possible contamination with Listeria monocytogenes in bFDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related events
FDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related eventsLibby Laboratories, Inc. – 708259 – 06/27/2025
CGMP/Finished Pharmaceuticals/Adulterated